Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 1, 2005

Published online before print January 14, 2005
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0904514v1
77/4/568    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosque, A.
Right arrow Articles by Anel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosque, A.
Right arrow Articles by Anel, A.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0904514


Received for publication September 15, 2004.
Revised November 15, 2004.
Accepted for publication December 9, 2004.


Article

Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression

Alberto Bosque *, Julián Pardo *, Mª José Martínez-Lorenzo {dagger}, María Iturralde *, Isabel Marzo *, Andrés Piñeiro *, Mª Angeles Alava *, Javier Naval *, and Alberto Anel *@

*Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and {dagger}Servicio de Inmunología, Hospital Clínico Universitario, Universidad de Zaragoza, Spain

@ To whom correspondence should be addressed. E-mail: anel{at}posta.unizar.es.


   Abstract

A systematic study was undertaken to characterize the role of apolipoprotein 2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (APO2L/TRAIL) and Fas ligand (FasL) together with the expression of several anti- or proapoptotic proteins in the down-regulation of normal human T cell responses. We have observed for the first time that the higher sensitivity of normal human T cell blasts to apoptosis and activation-induced cell death (AICD) as compared with naïve T cells correlates with the increased expression of Bcl-x short (Bcl-xS) and Bim. T cell blasts die in the absence of interleukin 2 (IL-2) with no additional effect of death receptor ligation. In the presence of IL-2, recombinant APO2L/TRAIL or cytotoxic anti-Fas monoclonal antibodies induce rather than inhibit IL-2-dependent growth and not cell death on normal human T cell blasts. This observation is of physiological relevance, as supernatants from T cell blasts, pulse-stimulated with phytohemagglutinin (PHA) or through CD3 or CD59 ligation and containing bioactive APO2L/TRAIL and/or FasL expressed on microvesicles or direct CD3 or CD59 ligation, had the same effect. Cell death was only observed in the presence of cycloheximide or after a pulse through CD3 or CD59, correlating with a net reduction in cellular Fas-associated death domain-like IL-1{beta}-converting enzyme-inhibitory protein long (c-FLIPL) and c-FLIPS expression. We also show that death receptor and free radical generation contribute, at least partially, to AICD induced by PHA and also to the inhibition of IL-2-dependent cell growth by CD3 or CD59 ligation. Finally, we have also shown that T cell blasts surviving PHA-induced AICD are memory CD44high cells with increased c-FLIPS and Bcl-xL expression.

Key Words: T lymphocytes • growth arrest • apoptosis




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Bosque, J. I. Aguilo, M. del Rey, E. Paz-Artal, L. M. Allende, J. Naval, and A. Anel
Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes
J. Leukoc. Biol., August 1, 2008; 84(2): 488 - 498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Meinander, T. S. Soderstrom, A. Kaunisto, M. Poukkula, L. Sistonen, and J. E. Eriksson
Fever-Like Hyperthermia Controls T Lymphocyte Persistence by Inducing Degradation of Cellular FLIPshort
J. Immunol., March 15, 2007; 178(6): 3944 - 3953.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Bosque, J. I. Aguilo, M. A. Alava, E. Paz-Artal, J. Naval, L. M. Allende, and A. Anel
The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling
Blood, February 15, 2007; 109(4): 1627 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
K. J. Rautajoki, E. M. Marttila, T. A. Nyman, and R. Lahesmaa
Interleukin-4 Inhibits Caspase-3 by Regulating Several Proteins in the Fas Pathway during Initial Stages of Human T Helper 2 Cell Differentiation
Mol. Cell. Proteomics, February 1, 2007; 6(2): 238 - 251.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Laudanski, C. Miller-Graziano, W. Xiao, M. N. Mindrinos, D. R. Richards, A. De, L. L. Moldawer, R. V. Maier, P. Bankey, H. V. Baker, et al.
Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways
PNAS, October 17, 2006; 103(42): 15564 - 15569.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Del-Rey, J. Ruiz-Contreras, A. Bosque, S. Calleja, J. Gomez-Rial, E. Roldan, P. Morales, A. Serrano, A. Anel, E. Paz-Artal, et al.
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome
Blood, August 15, 2006; 108(4): 1306 - 1312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Neujahr, C. Chen, X. Huang, J. F. Markmann, S. Cobbold, H. Waldmann, M. H. Sayegh, W. W. Hancock, and L. A. Turka
Accelerated Memory Cell Homeostasis during T Cell Depletion and Approaches to Overcome It.
J. Immunol., April 15, 2006; 176(8): 4632 - 4639.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Society for Leukocyte Biology.